Latest Posts

22

Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...
Read More

27

Mar 24

Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development

Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More

big data

What is Data Analysis?

We live in a data-driven world. The volume of data is exploding – created by private consumers, businesses and machines across the globe. 2025 the volume of global data is forecast to reach up to 180 zettabytes – that’s a figure with 21 zeros before the decimal. This includes information from business transactions, scientific research …

What is Data Analysis? Read More »

How AI and Big Data is transforming the future of healthcare

Dr. Gunjan Bhardwaj with Shanna Landolt for an exclusive podcast on how AI and Big Data is transforming the future of healthcare. http://traffic.libsyn.com/force-cdn/highwinds/shannalandolt/Dr._Gunjan_Bhardwaj.mp4 Gunjan Bhardwaj is the Founder and CEO of the Innoplexus group. He was earlier with the Boston Consulting Group and before that the leader of the global business performance think-tank of Ernst …

How AI and Big Data is transforming the future of healthcare Read More »

Why data analytics should be Pharma’s new core competency

Defining your company’s core competency—what you do really well—can set you apart and secure a trajectory of success. Pharma’s core competency has evolved over the years. Initially, it was research and companies that were fortunate enough to discover major blockbuster drugs enjoyed profitable periods of market exclusivity. However, once the pharma market consolidated into large …

Why data analytics should be Pharma’s new core competency Read More »

Is Open Data the silver bullet for better drugs?

Open data sharing within the pharmaceutical industry is crucial for opening the floodgates of innovation. Successful innovation depends on having a rich supply of high-quality data because, without the right kind and quantity of data, there wouldn’t be a foundation for the research required to innovate. The best way to achieve this critical mass of …

Is Open Data the silver bullet for better drugs? Read More »